Today's guest post comes from Kristen Magee, Vice President of Methodology & Enablement at AssistRx.
Kristen explains why patient support programs (PSPs) need to evolve as products move from launch through growth, maturity, and loss of exclusivity. She outlines how manufacturers can recalibrate the balance of technology, automation, and human support at each stage to improve efficiency while maintaining strong patient and healthcare provider experiences.
To learn more about AssistRx's approach to patient support across the product lifecycle, download the AssistRx lifecycle playbook suite.
Read on for Kristen's insights.
Drug Channels delivers timely analysis and provocative opinions on pharmaceutical economics and the drug distribution system. Drug Channels reaches an engaged, loyal and growing audience of more than 100,000 subscribers and followers. Learn more...
